XTalks

DECEMBER 29, 2022

The life sciences and healthcare are among the biggest industries globally, and their significance was particularly highlighted during the past couple of years by the COVID-19 pandemic. Given the hyperfocus on the life sciences thanks to COVID, consumers appear to be more autonomous and vocal about their medical demands and choices.

Life Science 52

Life Science Gene Therapy Gene Manufacturing 52

pharmaphorum

APRIL 4, 2022

Multinational insurance company AXA has launched a new €440 million ($500 million) drive to provide private equity investments in healthcare companies that deepens its interest in the life sciences sector. It is a major backer of Kadans, one of the groups behind the recently-announced Canary Wharf life sciences hub in east London.

Life Science 59

Life Science Vaccination Vaccine Marketing 59

XTalks

DECEMBER 17, 2021

Xtalks is taking a look at some of the major stories and innovations of the year in the life sciences, many of which were driven by new, emerging and improved technologies. The year continued to be dominated by COVID-19, and the second year of the pandemic was all about vaccines. COVID-19: The Pandemic and the Vaccines.

Life Science 98

Life Science Vaccination Vaccine Trials 98

pharmaphorum

MARCH 12, 2021

If the power of the life sciences industry to innovate and collaborate were ever in doubt, the speed at which vaccines for COVID-19 were discovered, developed, trialled, approved and manufactured have confirmed just how dynamic the industry can be. Building the data-powered life sciences business .

Life Science 111

Life Science Regulation Genome Genomics 111

XTalks

FEBRUARY 5, 2024

In the first year of the respiratory syncytial virus (RSV) vaccine battle, GlaxoSmithKline’s (GSK) Arexvy emerged as the winner over Pfizer’s Abrysvo. GSK declared Arexvy to be a blockbuster in its first year on the market after higher-than-expected sales. The company has reported the vaccine to be 83.7 billion or £1.2

Vaccination 59

Vaccination Vaccine Marketing Sales 59

pharmaphorum

JULY 7, 2021

The UK’s long-awaited Life Sciences Vision strategy has been published, setting out the government’s stall as it tries to deliver on its promise to keep the country at the forefront of the sector. ” The post Dementia, cancer headline UK’s 10-year plan for life sciences sector appeared first on.

Life Science 59

Life Science Manufacturing Genome Genomics 59

Pharmaceutical Technology

NOVEMBER 23, 2022

Innovations in biotechnology are advancing the biopharmaceutical market, enabling the treatment of complex diseases with next-generation therapeutics synthesised or extracted from a biological source. With around 35,000 employees, the broader life sciences sector is one of Hamilton’s largest industries.

Marketing 130

Marketing Gene Therapy Life Science Manufacturing 130

XTalks

MAY 6, 2021

But rather than looking at these circumstances as barriers, job seekers should keep an open mind and rest assured that there are a wide range of jobs in the life sciences fields, like the pharmaceutical and medical device industries. Sales and marketing. How the Pandemic has Changed the Job Market. Intellectual rights.

Life Science 91

Life Science Manufacturing Engineer Vaccination 91

pharmaphorum

DECEMBER 22, 2022

Construction will start early next year of a new manufacturing centre in the UK with the capacity to produce 250 million vaccine doses per year, the centrepiece of a 10-year alliance between the government and US biotech Moderna. The first vaccines are due to be produced at the new facility in 2025.

Vaccination 122

Vaccination Vaccine Life Science Manufacturing 122

XTalks

MAY 28, 2024

In a move signaling a major shift in influenza prevention strategies, CSL Seqirus, a global leader in flu vaccines, has transitioned from quadrivalent to trivalent formulations for the upcoming 2024/25 flu season in the US.

Vaccination 52

Vaccination Vaccine Clinical Trials Clinical Trials 52

Pharmaceutical Technology

MAY 2, 2023

ODAIA, a life sciences predictive analytics and commercial insights provider, has secured an investment of $25m in its Series B funding round. This software-as-a-service (SaaS) platform is also used by life science brands to launch their drugs, therapeutics and vaccines in the markets, using data-driven solution.

Life Science 147

Life Science Branding Pharma Companies Sales 147

Drug Discovery World

MAY 13, 2024

Reece Armstrong speaks to Melanie Adams-Cioaba , Senior Director and General Manager of pharma (cryo-EM), Thermo Fisher Scientific about advances in vaccine design. Using structural biology as central to vaccine design and development, and to drug discovery more generally, is what we mean by “rational design.”

Vaccination 59

Vaccination Vaccine Protein Antibody 59

XTalks

SEPTEMBER 1, 2023

GlaxoSmithKline (GSK) has been pumping large sums of cash into expanding its vaccine manufacturing operations and today, it announced an investment of €250 ($272 million) into building a new unit for freeze-drying vaccines at its Wavre campus in Belgium. The British drugmaker expects to produce tens of millions of vaccine doses a year.

Vaccination 98

Vaccination Vaccine Manufacturing Production 98

pharmaphorum

JULY 7, 2021

The ABPI’ s chief executive Dr Richard Torbett outlines a new ‘vision’ and 10-year strategy for UK life sciences, launched by the government today. After an extraordinary year of science versus disease, the UK has cemented itself at the forefront of the global response to COVID-19.

Life Science 59

Life Science Manufacturing Genome Genomics 59

NY Times

OCTOBER 27, 2020

With state and city government support, developers are building laboratories for medical research and incubator spaces for biotech start-ups amid the race for a coronavirus vaccine.

Life Science 56

Life Science Marketing Vaccination Vaccine 56

The Pharma Data

JUNE 1, 2022

AstraZeneca’s Chief Executive Officer, Pascal Soriot, today received a British knighthood for services to UK life sciences and leadership in the global response to the COVID pandemic in the Queen’s Birthday Honours 2022. AstraZeneca also played a critical role in the global response to COVID-19.

Life Science 52

Life Science Medicine Vaccination Vaccine 52

Drug Channels

NOVEMBER 8, 2020

16th Annual Life Sciences Trade and Channel Strategies. That’s why the life science industry’s top experts will come together virtually on December 1-3 at Trade and Channel 2020. December 1-3, 2020 | Virtual Event www.informaconnect.com/trade-channel. Stuart Parker, Senior Director, Trade Relations, Mayne Pharma And more!

Life Science 52

Life Science Pharmacy Gene Therapy Branding 52

XTalks

OCTOBER 31, 2023

GlaxoSmithKline (GSK) Canada has roped in both older and younger versions of Wayne Gretzky for a new ad for its respiratory syncytial virus (RSV) vaccine Arexvy. The RSV vaccine ad has the now 62-year-old hockey legend looking into a mirror and seeing his younger self, specifically an AI-generated 20-year-old version of himself.

Vaccination 97

Vaccination Vaccine FDA Approval Development 97

Drug Channels

OCTOBER 19, 2020

16th Annual Life Sciences Trade and Channel Strategies. December 1-3, 2020 | Virtual Event www.informaconnect.com/trade-channel. Get ready to hit the ground running in 2021 by closing out the year at Trade and Channel 2020 !

Life Science 52

Life Science Pharmacy Gene Therapy Gene 52

Drug Discovery World

MARCH 30, 2023

Likang Life Sciences has been granted implied approval by China’s National Medical Products Administration (NMPA) for the clinical trial of its innovative personalised neoantigen-targeted vaccine LK101 Injection for advanced solid tumours. Hence, there is a need to increase clinical investigations in this promising area.”

Regulation 52

Regulation Vaccination Vaccine Trials 52

The Pharma Data

MARCH 15, 2022

Global Head of Blackstone Life Sciences “We are excited to collaborate with Sanofi’s experienced development team to advance a subcutaneous dosage form for Sarclisa for patients. About Blackstone Life Sciences. Nicholas Galakatos, Ph.D. Sanofi is listed on EURONEXT: SAN and NASDAQ: SNY.

Life Science 52

Life Science Antibody Clinical Trials Clinical Trials 52

pharmaphorum

JULY 19, 2021

A new report published by Medicines Discovery Catapult and CPI details the huge medical and market potential for complex medicines in the UK. Lipid nanoparticles as carriers of next-generation vaccines also came to global prominence in 2021 as the platform for both the Pfizer-BioNTech and the Moderna COVID-19 vaccines.

Life Science 52

Life Science Medicine RNA Vaccination 52

Pharmaceutical Technology

AUGUST 1, 2022

Before the Covid-19 pandemic, government-led investment and engagement in life sciences was relatively restricted worldwide, with the industry mostly funded via private investment. This included more than £6bn ($7.3bn) being made available by the UK Government in November 2020 for the development and procurement of successful vaccines.

Vaccination 234

Vaccination Vaccine Bacteria Life Science 234

pharmaphorum

NOVEMBER 26, 2020

The UK’s pharma industry trade body has warned that Brexit could derail the government’s efforts to get coronavirus vaccines to the population, but welcomed other measures in this week’s spending review aimed at reviving the economy after the pandemic.

Vaccination 105

Vaccination Vaccine Life Science Regulation 105

Pharmaceutical Technology

AUGUST 30, 2022

Verista is a Life Sciences business, technology and compliance firm specializing in systems, quality, and validation solutions throughout the product lifecycle. The firm has a clear strategy of aggressively creating and expanding its organization to meet the ever-growing needs of an underserved market. The Verdict.

Life Science 130

Life Science Compliance Manufacturing Marketing 130

pharmaphorum

DECEMBER 16, 2022

Ben Hargreaves discovers why some have referred to the distribution of COVID-19 vaccines and treatments as a form of apartheid. Vaccine access for a price. Tendayi Achium, labelled the response by the global community as a form of “vaccine apartheid,” a suggestion echoed by the organisation’s director general.

Vaccination 96

Vaccination Vaccine Production Licensing 96

XTalks

OCTOBER 25, 2023

The US Food and Drug Administration (FDA) has accepted AstraZeneca’s supplemental biologics license application (sBLA) for a self-administered option of its nasal influenza vaccine FluMist Quadrivalent. FluMist has been in the market since 2003 and is the only intranasal spray vaccine option against flu.

Vaccination 59

Vaccination Vaccine Sales Pharmacy 59

BioPharma Reporter

JANUARY 20, 2021

US government non-dilutive funding has played a key role in the accelerated development of the COVID-19 vaccine.

Life Science 97

Life Science Vaccination Vaccine Development 97

XTalks

NOVEMBER 10, 2021

Ayesha and the team discussed the convenience of an oral medication for COVID-19, and how such drugs appear to be more accepted than preventative vaccines among some circles of people. With almost half of all adult Americans having the condition, there is a significant market for new treatments in the area.

Life Science 52

Life Science FDA Approval Trials Vaccination 52

XTalks

OCTOBER 4, 2023

Health economics and outcomes research (HEOR) and market access strategies play a critical role in ensuring that newly approved therapies are made available to patients. Professionals in these roles are facing new challenges when it comes to negotiating coverage for many of the new, innovative treatments that are coming to market.

Marketing 105

Marketing Development Drugs Gene Therapy 105

XTalks

JUNE 30, 2021

The device received FDA 510(k) clearance, allowing for marketing of the system before its final approval. The team also discussed AstraZeneca’s legal troubles and how it has won in the latest hearing of a lawsuit launched by the European Commission over failure to deliver on the promised number of doses of its COVID-19 vaccine to the EU.

Vaccination 97

Vaccination Vaccine Life Science Manufacturing 97

pharmaphorum

JULY 20, 2021

The EMA has kicked off a rolling review of a COVID-19 vaccine from Sanofi and GlaxoSmithKline, which started a 35,000-patient phase 3 trial in May. So far the EU has approved four COVID-19 vaccines – two mRNA shots from Pfizer/BioNTech and Moderna, and two based on adenoviral vectors from AstraZeneca and Johnson & Johnson.

Vaccination 98

Vaccination Vaccine Protein Immune Response 98

pharmaphorum

JANUARY 27, 2021

A plant in Wales manufacturing the AstraZeneca COVID-19 vaccine was evacuated on the advice of the authorities today after it was sent a suspicious package. The contract covers production of 100 million doses of the AZ vaccine. Wockhardt UK in Wrexham this morning received a suspicious package.

Vaccination 98

Vaccination Vaccine Packaging Packaging 98

BioPharma Reporter

MAY 11, 2021

RoslinCT is set to collaborate with the Scottish Universities Life Sciences Alliance (SULSA) and additional academic institutions to deliver high impact advanced therapy and vaccine manufacturing GMP training.

Manufacturing 52

Manufacturing Vaccination Vaccine Life Science 52

XTalks

JULY 28, 2021

Merck has scored US Food and Drug Administration (FDA) approval for its next-generation pneumonia vaccine Vaxneuvance that covers 15 different strains of the pneumococcal bacteria that causes the infection. This is seven more strains than its current winning vaccine Prevnar 13, which registered $5.95

FDA Approval 89

FDA Approval Vaccination Vaccine Immune Response 89

XTalks

SEPTEMBER 21, 2023

announced that the first participant has been dosed in a new Phase I trial for an innovative HIV vaccine candidate, VIR-1388. Since 2004, the NIAID has been championing the discovery and development of the cytomegalovirus (CMV) vector used to deliver the HIV vaccine material to the immune system without causing disease.

Vaccination 59

Vaccination Vaccine Trials Clinical Trials 59

pharmaphorum

OCTOBER 13, 2022

In this episode of the pharmaphorum podcast series, Dr Paul Tunnah chats with Jeff Baxter, CEO of VBI Vaccines and Lee Taurman, executive vice president full service commercial at Syneos Health. Lee Taurman is an experienced Life Sciences industry executive and management consultant. About the interviewees.

Vaccination 52

Vaccination Vaccine Life Science Development 52